Bridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions

Welcome to the premiere episode of Season 2 on the “Cut The Chat – Life Science Insider Podcast”. This season, we kick off with an invigorating dialogue between our host, Sabine Hutchison, CEO and Co-Founder of Seuss+, and the remarkable Stephanie Oestreich, Managing Director at the Myeloma Investment Fund (MIF).

At MIF, Stephanie uses the investment and drug development knowledge and skills she has gained in several leadership roles in biotech and big pharma.

In this engaging conversation, Sabine talks to Stephanie about the challenges involved in running a specialty fund, and what she looks for in potential investments. Stephanie shares that MIF’s North Star is finding a cure for patients, and why it’s valuable for investors to visit clinical trial sites to see their work in action.

Stephanie Oestreich Bio

Stephanie Oestreich is Managing Director of the Myeloma Investment Fund (MIF). She serves on the boards of the German American Business Council in Boston and the Harvard Kennedy School’s Women’s Network and is the chair of the McCloy Alumni Association.

She is also on the faculty of MIT, a member of the Launchpad Venture Group, an advisor at grIP Venture Studio, to Biognosys (a Bruker company), Invitris, CART company CelineTx and to the drug development and investment company OrangeGrove Bio, Additionally she works on the W20 Entrepreneurship task force, the official engagement group of the G20.

Stephanie has held several leadership roles in biotech, including Chief Business Officer at Galecto, Vice President at cell therapy company Mnemo Therapeutics, Venture Partner at RA Capital and Executive Vice President at Evotec, where she built its North American investment arm and started an incubator with Samsara BioCapital. She has worked as International Business Leader at F. Roche Hoffmann-La Roche Ltd., and for Novartis in Business Development and in Commercial.

Stephanie conducted the research for her Ph.D. in biochemistry in the lab of a Nobel Prize winner at Harvard Medical School and obtained an MPA from the Harvard Kennedy School.

Join the discussion and listen to the full episode here.